Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.
During law school, Eric served as an extern with the UC Davis Technology Transfer Office, Innovation Access, where he performed threshold patent analysis and drafted contracts and licenses. He also assisted service members in the Armed Forces as an extern for the United States Air Force Judge Advocate General at Travis Air Force Base, and worked as an extern for Justice Nathan Mihara of the California Court of Appeal for the Sixth District on a wide variety of civil and criminal appeals.
Prior to attending law school, Eric worked in flu vaccine research and development for MedImmune Inc.
Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.
During law school, Eric served as an extern with the UC Davis Technology Transfer Office, Innovation Access, where he performed threshold patent analysis and drafted contracts and licenses. He also assisted service members in the Armed Forces as an extern for the United States Air Force Judge Advocate General at Travis Air Force Base, and worked as an extern for Justice Nathan Mihara of the California Court of Appeal for the Sixth District on a wide variety of civil and criminal appeals.
Prior to attending law school, Eric worked in flu vaccine research and development for MedImmune Inc.